METHOD FOR THE TREATMENT OF CEREBRAL ISCHAEMIA AND USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHAEMIA.

摘要

The invention relates to a method for the treatment of cerebral ischaemia and to an agent for the treatment of cerebral ischaemia, notably in humans, of the kind seen, for example, in stroke patients. Surprisingly it was found that the peripheral administration of erythropoietin to ischaemic cerebral tissue has a marked protective effect. Erythropoietin dramatically reduces the area of permanently damaged cerebral tissue, notably in the penumbra, in comparison to results obtained with conventional measures without administration of erythropoietin.